Vistagen Therapeutics (VTGN) EBITDA Margin (2010 - 2026)
Vistagen Therapeutics' EBITDA Margin came in at -7889.13% for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 137.19 percentage points from -7751.94% a year earlier and down 6988.32 percentage points from the prior quarter.
Vistagen Therapeutics (VTGN) EBITDA Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Vistagen Therapeutics reported EBITDA Margin of -2533.17%, up 6523.70 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -5668.01%, up 5818.21 percentage points from FY2025.
- EBITDA Margin carries a five-year change of -4032.74 percentage points (FY2021 to FY2026).
- Going back by fiscal year, EBITDA Margin was -11486.21% in FY2025 (-8394.67 pp), -3091.54% in FY2024 (+22960.44 pp), -26051.98% in FY2023 (-21757.53 pp) and -4294.45% in FY2022 (-2659.19 pp).
- The fiscal Q2 2027 figure represents the lowest quarterly EBITDA Margin since fiscal Q1 2025.
- Year-over-year, EBITDA Margin increased in four of the last six quarters, with an average year-over-year change of +1473.84 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in fiscal Q4 2023 (a gain of 35768.82 percentage points), and the weakest in fiscal Q4 2022 (a drop of 41305.69 percentage points).
- Business Quant data shows VTGN's EBITDA Margin at -900.81% (Q1 2027), -3583.87% (Q4 2026) and -6433.00% (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -883.96% |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 36.69% |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 32.68% |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 46.88% |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 40.60% |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 50.63% |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - | -7,889.13% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -7,889.13% |
| Jun 30, 2026 | -900.81% |
| Mar 31, 2026 | -3,583.87% |
| Dec 31, 2025 | -6,433.00% |
| Sep 30, 2025 | -7,751.94% |
| Jun 30, 2025 | -6,460.66% |
| Dec 31, 2024 | -6,444.87% |
| Sep 30, 2024 | -7,754.10% |
| Jun 30, 2024 | -14,401.19% |
| Mar 31, 2024 | -6,906.10% |
| Dec 31, 2023 | -1,910.71% |
| Sep 30, 2023 | -2,249.67% |
| Jun 30, 2023 | -3,483.00% |
| Mar 31, 2023 | -6,934.77% |
| Dec 31, 2022 | -5,408.83% |
| Sep 30, 2022 | -1,954.76% |
| Jun 30, 2022 | -6,365.95% |
| Mar 31, 2022 | -42,703.59% |
| Dec 31, 2021 | -2,931.65% |
| Sep 30, 2021 | -3,565.17% |
Vistagen Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();